Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
PainChek Ltd ( (AU:PCK) ) has provided an announcement.
PainChek Ltd, an Australian developer of AI-based medical devices for pain assessment, has built a global footprint spanning Australia, North America, Europe and parts of Asia, where its smartphone and tablet app supports best-practice pain management in aged care and other clinical settings. The company has regulatory clearance in multiple major jurisdictions and is already embedded in over 2,000 aged care facilities, underscoring its focus on digitally transforming pain assessment for residents who struggle to self-report.
The company has signed a master services agreement with Sabra Health Care REIT that will see Sabra fund PainChek’s deployment for up to 20,000 beds across 329 skilled nursing, long-term care and senior housing facilities in the U.S. and Canada. The owner-funded, per-bed pricing model is expected to accelerate adoption, lower sales and marketing costs and provide a scalable template for similar rollouts with other large healthcare real estate investment trusts in North America, strengthening PainChek’s position in the aged care technology market following its U.S. regulatory approval.
More about PainChek Ltd
PainChek Ltd is an Australian medical technology company that develops an AI-powered pain assessment and monitoring application used via smartphones and tablets. Its regulatory-cleared device targets pain management for people who cannot reliably self-report, those who can, and those with fluctuating ability, with a strong focus on aged care and senior living facilities across global markets including Australia, the U.S., Canada, Europe and Asia. PainChek’s tools are used in more than 2,000 aged care facilities and have supported over 18 million digital pain assessments, positioning the company as a specialist provider of digital clinical tools for nurses, carers and clinicians in long-term and residential care settings.
Average Trading Volume: 162,761
Technical Sentiment Signal: Sell
Current Market Cap: A$31.35M
For a thorough assessment of PCK stock, go to TipRanks’ Stock Analysis page.